/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Santiago Roel Santos

Elysium Therapeutics (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

3

Papers

185

Citations

2

h-index

1

i10-index

Santiago Roel Santos is an academic researcher from Elysium Therapeutics (United States). The author has contributed to research in topics: Sirtuins and Resveratrol in Medicine & Mitochondrial Function and Pathology & Adipose Tissue and Metabolism. The author has an h-index of 2, co-authored 3 publications.

Research Topics

Sirtuins and Resveratrol in Medicine Mitochondrial Function and Pathology Adipose Tissue and Metabolism PARP inhibition in cancer therapy Calcium signaling and nucleotide metabolism

Papers by this author

works

Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

2017 · npj Aging and Mechanisms of Disease · 180 citations

https://doi.org/10.1038/s41514-017-0016-9

Ryan W. Dellinger Santiago Roel Santos Mark Morris Malkanthi Evans

Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

2018 · npj Aging and Mechanisms of Disease · 2 citations

https://doi.org/10.1038/s41514-018-0027-1

Ryan W. Dellinger Santiago Roel Santos Mark Morris Malkanthi Evans

Research topics

topics

Sirtuins and Resveratrol in Medicine

Mitochondrial Function and Pathology

Adipose Tissue and Metabolism

PARP inhibition in cancer therapy

Calcium signaling and nucleotide metabolism

Chat about Author

Papers

Chat

Click to start Chat